| Title |
Drug Treatment of Hypertension in Pregnancy
|
|---|---|
| Published in |
Drugs, February 2014
|
| DOI | 10.1007/s40265-014-0187-7 |
| Pubmed ID | |
| Authors |
Catherine M. Brown, Vesna D. Garovic |
| Abstract |
Hypertensive disorders represent major causes of pregnancy-related maternal mortality worldwide. Similar to the non-pregnant population, hypertension is the most common medical disorder encountered during pregnancy and is estimated to occur in about 6-8 % of pregnancies. A recent report highlighted hypertensive disorders as one of the major causes of pregnancy-related maternal deaths in the USA, accounting for 579 (12.3 %) of the 4,693 maternal deaths that occurred between 1998 and 2005. In low-income and middle-income countries, preeclampsia and its convulsive form, eclampsia, are associated with 10-15 % of direct maternal deaths. The optimal timing and choice of therapy for hypertensive pregnancy disorders involves carefully weighing the risk-versus-benefit ratio for each individual patient, with an overall goal of improving maternal and fetal outcomes. In this review, we have compared and contrasted the recommendations from different treatment guidelines and outlined some newer perspectives on management. We aim to provide a clinically oriented guide to the drug treatment of hypertension in pregnancy. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 14% |
| New Zealand | 1 | 7% |
| United Kingdom | 1 | 7% |
| Costa Rica | 1 | 7% |
| Unknown | 9 | 64% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 64% |
| Practitioners (doctors, other healthcare professionals) | 4 | 29% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 361 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Nigeria | 1 | <1% |
| Tanzania, United Republic of | 1 | <1% |
| Egypt | 1 | <1% |
| Unknown | 358 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 63 | 17% |
| Student > Master | 42 | 12% |
| Researcher | 32 | 9% |
| Student > Postgraduate | 27 | 7% |
| Student > Doctoral Student | 23 | 6% |
| Other | 65 | 18% |
| Unknown | 109 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 133 | 37% |
| Pharmacology, Toxicology and Pharmaceutical Science | 29 | 8% |
| Nursing and Health Professions | 26 | 7% |
| Biochemistry, Genetics and Molecular Biology | 13 | 4% |
| Neuroscience | 6 | 2% |
| Other | 31 | 9% |
| Unknown | 123 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 375. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2023.
All research outputs
#79,605
of 24,652,007 outputs
Outputs from Drugs
#3
of 3,419 outputs
Outputs of similar age
#616
of 229,710 outputs
Outputs of similar age from Drugs
#2
of 29 outputs
Altmetric has tracked 24,652,007 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,419 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 229,710 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.